Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidoglycan pentapeptide precursors are essential intermediate molecules in the biosynthesis of the bacterial cell wall, primarily in Gram-positive bacteria [StatPearls, 2023]. These precursors consist of a sugar backbone (N-acetylglucosamine and N-acetylmuramic acid) attached to a pentapeptide chain, typically ending in a D-alanyl-D-alanine (D-Ala-D-Ala) motif [Nature Reviews Microbiology, 2008]. During cell wall assembly, these precursors are linked to a lipid carrier to form Lipid II, which is then translocated across the cytoplasmic membrane [PubMed, 2015]. Once on the exterior, the precursors are incorporated into the growing peptidoglycan polymer through the actions of transglycosylases and transpeptidases [Microbiology and Molecular Biology Reviews, 2009]. This target is the primary site of action for glycopeptide antibiotics, such as vancomycin, which bind to the D-Ala-D-Ala terminus via hydrogen bonding [PubChem, 2024]. This binding sterically inhibits the enzymatic cross-linking of the cell wall, leading to weakened structural integrity and eventual bacterial cell lysis [StatPearls, 2023]. Resistance mechanisms, such as those found in Vancomycin-Resistant Enterococci (VRE), involve the substitution of the terminal D-alanine with D-lactate or D-serine, which prevents antibiotic binding while still allowing cell wall synthesis [CDC, 2019].
Glycopeptide antibiotics bind to the D-alanyl-D-alanine terminus of the peptidoglycan pentapeptide precursor, forming a stable complex via five hydrogen bonds [StatPearls, 2023]. This binding sterically hinders the transglycosylation and transpeptidation steps of cell wall synthesis [Nature Reviews Microbiology, 2008]. Consequently, the bacterial cell wall becomes structurally compromised, leading to osmotic lysis and cell death [PubChem, 2024].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan pentapeptide precursor.